Tissue Regenix Group PLC (FRA:LSW)
€ 0.705 0.01 (1.44%) Market Cap: 52.42 Mil Enterprise Value: 58.92 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 42/100

Half Year 2021 Tissue Regenix Group PLC Earnings Call Transcript

Sep 08, 2021 / 03:30PM GMT
Marc Downes
Investor Meet Company - Moderator

Good afternoon, ladies and gentlemen, and welcome to the Tissue Regenix Group plc investor presentation for the interim results for the six months of 30th of June 2021. (Event Instructions)

The company may not be in a position to answer every question received during the meeting itself. However, the company review all questions submitted today and publish responses where it's appropriate to do so. These will be available via your Investor Meet Company dashboard, and you'll be notified once they're ready for your review.

I also like to remind you this presentation is being recorded. Before we begin, we'd like to submit the following poll.

I'd now like to hand you over to Daniel Lee, CEO; and David Cocke, CFO of Tissue Regenix Group plc.

Good afternoon.

Daniel Lee
Tissue Regenix Group plc - CEO

Good -- Hello. Thank you, Marc, and thank you to your investors for sharing some of your valuable time with us today, to give us the opportunity to provide an interim update on Tissue

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot